Emerging Role of Lipids in Metabolism and Disease
Even though initially considered as a passive means for storing energy, lipids are now regarded as multifaceted molecules with crucial structural and functional activities. For instance, some of them play essential roles as key components of cell membranes whereas others act as signaling molecules i...
Saved in:
Other Authors: | , |
---|---|
Format: | Book Chapter |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
Subjects: | |
Online Access: | Get Fullteks DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 05263naaaa2201453uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_68544 | ||
005 | 20210501 | ||
020 | |a books978-3-03943-702-3 | ||
020 | |a 9783039437016 | ||
020 | |a 9783039437023 | ||
024 | 7 | |a 10.3390/books978-3-03943-702-3 |c doi | |
041 | 0 | |a English | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Pallottini, Valentina |4 edt | |
700 | 1 | |a Segatto, Marco |4 edt | |
700 | 1 | |a Pallottini, Valentina |4 oth | |
700 | 1 | |a Segatto, Marco |4 oth | |
245 | 1 | 0 | |a Emerging Role of Lipids in Metabolism and Disease |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
300 | |a 1 electronic resource (308 p.) | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Even though initially considered as a passive means for storing energy, lipids are now regarded as multifaceted molecules with crucial structural and functional activities. For instance, some of them play essential roles as key components of cell membranes whereas others act as signaling molecules in the regulation of cell homeostasis. In recent years, lipid research has attracted increasing interest because of the involvement of this class of compounds in human health. Indeed, a plethora of pathological conditions are characterized by alterations in lipid metabolism, such as cardiovascular diseases and brain disorders. This Special Issue is a collection of papers from different experts in lipid research, with the aim of providing new insights into the physiopathological involvement of lipids and their impact on human health. This collection also demonstrates the usefulness of interdisciplinary approaches in the development of novel methods to study and manipulate lipid metabolism, which may represent an attractive target for designing effective therapeutic strategies to counteract numerous pathologies. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a neutral sphingomyelinase | ||
653 | |a radiation | ||
653 | |a sphingomyelin metabolism | ||
653 | |a pathology | ||
653 | |a cell signaling | ||
653 | |a brain | ||
653 | |a adipose tissue | ||
653 | |a breast cancer | ||
653 | |a epinephrine | ||
653 | |a breast reconstruction | ||
653 | |a epicardial fat thickness | ||
653 | |a visceral fat thickness | ||
653 | |a high-sensitivity c-reactive protein | ||
653 | |a leptin | ||
653 | |a gender | ||
653 | |a female | ||
653 | |a hippocampus | ||
653 | |a frontal cortex | ||
653 | |a adiponectin | ||
653 | |a haptoglobin | ||
653 | |a lipocalin | ||
653 | |a BDNF | ||
653 | |a synaptic proteins | ||
653 | |a phosphatidylinositol 4,5-bisphosphate | ||
653 | |a phospholipase C | ||
653 | |a cholesterol | ||
653 | |a high-cholesterol diet | ||
653 | |a BET proteins | ||
653 | |a cell proliferation | ||
653 | |a epigenetics | ||
653 | |a HMGCR | ||
653 | |a JQ1 | ||
653 | |a LDLr | ||
653 | |a lipid metabolism | ||
653 | |a SREBP | ||
653 | |a TMEM97 | ||
653 | |a atherosclerosis | ||
653 | |a diabetes mellitus | ||
653 | |a cardiovascular disease | ||
653 | |a chronic inflammation | ||
653 | |a hyperglycemia | ||
653 | |a mutations | ||
653 | |a lipid | ||
653 | |a fatty acid | ||
653 | |a glyceride | ||
653 | |a steroid | ||
653 | |a phospholipid | ||
653 | |a oral drug absorption | ||
653 | |a prodrug | ||
653 | |a phospholipase A2 (PLA2) | ||
653 | |a acid sphingomyelinase | ||
653 | |a SOD | ||
653 | |a liver | ||
653 | |a eicosanoids | ||
653 | |a ischemic stroke | ||
653 | |a ischemia | ||
653 | |a lipoproteins | ||
653 | |a polyunsaturated fatty acids | ||
653 | |a angiogenesis | ||
653 | |a high-density lipoprotein | ||
653 | |a endothelial cell | ||
653 | |a metabolism | ||
653 | |a metabolic reprogramming | ||
653 | |a pulmonary fibrosis | ||
653 | |a lipid mediators | ||
653 | |a sphingolipids | ||
653 | |a sphingosine-1-phosphate | ||
653 | |a sphingosine kinase 1 | ||
653 | |a prostaglandins | ||
653 | |a lysophosphatidic acid | ||
653 | |a autotaxin | ||
653 | |a G-protein coupled receptors | ||
653 | |a lysocardiolipin acyltransferase | ||
653 | |a phospholipase D | ||
653 | |a oxidized phospholipids | ||
653 | |a DNA damage response | ||
653 | |a double strand breaks | ||
653 | |a ATM | ||
653 | |a ionizing radiation | ||
653 | |a metabolic stress | ||
653 | |a oxidative stress | ||
653 | |a p53 | ||
653 | |a nuclear sphingolipids | ||
653 | |a lipophagy | ||
653 | |a lipolysis | ||
653 | |a lipid droplets | ||
653 | |a lipid storage diseases | ||
653 | |a lipid metabolism diseases | ||
653 | |a mTORC1 | ||
653 | |a TFEB | ||
653 | |a Cholesterol | ||
653 | |a Fatty acids | ||
653 | |a Lipid mediators | ||
653 | |a Lipids | ||
653 | |a Lipophagy | ||
653 | |a Sphingolipids | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/3565 |7 0 |z Get Fullteks |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/68544 |7 0 |z DOAB: description of the publication |